Advanced Search

 

Study ID Status Title Patient Level Data
112355 Completed A Randomized, Double-Blind, Parallel-Group, 16-Week Study to Evaluate the Effect of Fluticasone Propionate/Salmeterol DISKUS® 250/50mcg BID and Placebo on Arterial Stiffness in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
112356 Completed A randomised, double-blind, placebo-controlled, 3-period cross-over study to evaluate the effect of two doses of GSK2190915 on the allergen-induced early asthmatic response in subjects with mild asthma Study Listed on ClinicalStudyDataRequest.com
112359 Completed A single centre, randomised, double-blind, placebo-controlled, four-way cross over study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of GSK2190915 in healthy Japanese subjects. Study Listed on ClinicalStudyDataRequest.com
112362 Completed An open label, sequential, single cohort, repeat dose study to investigate the potential interaction of GSK2190915 on the pharmacokinetics of rosuvastatin in healthy adult subjects. Study Listed on ClinicalStudyDataRequest.com
112495 Completed A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of TREXIMA™* in the Acute Treatment of Migraine Headaches Study Listed on ClinicalStudyDataRequest.com
112496 Completed A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of TREXIMA™*in the Acute Treatment of Migraine Headaches Study Listed on ClinicalStudyDataRequest.com
112497 Completed An Open-Label, Repeat Dose Study of the Safety of Combo Formulation in the Treatment of Multiple Episodes of Acute Migraine Over 12 Months. Study Listed on ClinicalStudyDataRequest.com
112509 Completed Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS)
112571 Completed A double-blind, randomized, placebo controlled Phase II study to evaluate the pharmacodynamics, safety, tolerability, and pharmacokinetics of Single Doses of the Oral Motilin Receptor Agonist GSK962040, in critically ill male and female patients with enteral feed intolerance Study Listed on ClinicalStudyDataRequest.com
112595 Completed Impact on nasopharyngeal carriage, acute otitis media, immunogenicity and safety of GSK Biologicals’ pneumococcal conjugate vaccine 1024850A Study Listed on ClinicalStudyDataRequest.com
112597 Completed Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
112598 Completed Adherence of patients taking 5ARI vs 5ARI + alpha blocker combination therapy in Enlarged Prostate
112599 Completed Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment
112604 Completed Comparison of Healthcare Utilization and Costs in Patients with Asthma who Fluticasone/Salmeterol Inhalation Powder versus other Inhaled Corticosteroid(s) in Typical Clinical Practice Using Health Insurance Claims Data.
112605 Completed Outcomes for Medicare asthma patients taking fluticasone propionate/salmeterol xinafoate combination versus Inhaled Corticosteroids or other combination therapy
112606 Completed Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
112607 Completed Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
112608 Completed Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects that Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
112609 Completed Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate–Salmeterol Combination Versus Other Maintenance Therapies
112611 Completed Prescription Patterns, Resource Utilization & Costs - Add-on Therapy with Anti Dipeptidyl Peptidase-IVs vs rosiglitazone
112640 Completed Immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals’ pneumococcal vaccine GSK1024850A following primary and booster vaccination of healthy Japanese children Study Listed on ClinicalStudyDataRequest.com
112646 Completed Outcomes and Costs Associated with initiating Maintenance Treatment with Fluticasone Propionate 250mcg/Salmeterol xinafoate 50mcg Combination (FSC) Versus Anticholinergics including Tiotropium (TIO) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
112648 Completed An open-label, randomized, single sequence, two period study to assess the effect of repeat oral dosing of ketoconazole on the pharmacokinetics of a single oral dose of GSK962040 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
112657 Completed A double-blind, randomized, placebo controlled, dose escalation, multi-centerphase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20antibody, in patients with active rheumatoid arthritis who have previously failedone or more disease modifying anti-rheumatic drugs
112662 Completed Immunogenicity and safety study of GSK Biologicals’ influenza vaccine GSK2186877A in elderly adults. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.